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Rapid outbreak of the coronavirus disease 2019 (COVID-19) has led to an unprecedent-ed knockdown of health systems worldwide. During the first weeks of the pandemic, a rapidly growing number of patients required immediate hospitalization, and many 
of them were admitted to intensive care units (ICU). Human, economic, and medical re-
sources have been redistributed to fight against the pandemic spread. Widely varied rates 
of virus evolution in terms of time and severity have been observed between the nations, 
and whilst this allows us to theorize on the course of the disease, many uncertainties remain 
as how the disease will evolve in the short- to midterm (1).
Narrowing to the field of interventional radiology (IR), we have been forced to adapt our 
practices to this situation in a very short period of time. An abrupt stop was made to daily 
practices, with priority being given to only the most urgent oncologic and trauma proce-
dures, and other basic services necessary to fight against the disease on the front line.
The purpose of this article is to explore how IR may evolve over the next 1–3 years. The 
authors do not pretend to predict or fix ideas about what will happen, rather, they share 
hypothesis on what may occur, with the aim to spark meaningful reflection and debate. 
This article has been designed to inspire bold thinking about this inevitable era of change 
and opportunity, always with the conviction that our “resilient” specialty will prevail as it has 
done for generations.
Stages of the pandemic and IR procedures
The course of the COVID-19 infection has been represented as an epidemic curve that 
shows progression of illnesses in an outbreak over time (Fig. 1). 
In the early stages of the “emergency phase” (the period of time until the peak of ac-
tive cases is reached), when more than 75% of the hospital admissions were identified as 
COVID-19 patients, IR units ceased daily activities. From this point, emergent procedures 
(e.g., bleeding embolization, acute dialysis interventions, TIPS, ruptured EVAR, nephros-
tomy), and selected nondeferrable oncologic treatments (e.g., ports), were performed. 
Non-priority procedures (e.g., ovarian vein embolization) were rescheduled or postponed 
until further notice (2–5).
Only once a health system enters the “mitigation phase”, demonstrates a flattening of the 
curve, and experiences a reduction of new cases (25%–75%), an attempt to recover common 
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IR activities may start. Initially, IR units will 
need to be redesigned to create COVID/non-
COVID-19 circuits, and to prepare for future 
pandemic waves. Until this is accomplished, 
secondary procedural priorities (e.g., TACE, 
ablations) will not commence. In this phase, 
it will be essential to establish circuits and 
create protocols, though problems may arise 
due to uncertainty surrounding the immu-
nological status of particular patients who 
access the angiography suite.
The third phase will arise during the 
“recovery stage” with the progressive res-
toration of normal hospital activity (<25% 
COVID-19). As soon as a safe virus environ-
ment is assured, common IR procedures will 
be performed. A surge of patient population 
can be reasonably expected considering 
the number of rescheduled or postponed 
appointments for non-critical procedures 
when the disease was prevalent.
COVID-19 has also modified the way in 
which IR procedures were performed. During 
the emergency phase, there was a tendency 
to perform bedside procedures for a variety 
of reasons, such as the clinical status of the 
patient, the insufficient staff or personnel to 
transfer patients, and the incomplete adap-
tation of the IR unit (3, 4). IR procedures were 
carried out in ICU, internal medicine wards, 
and even makeshift hospitals, under ultra-
sonography, in adverse conditions. Most 
frequent interventions were the application 
of vascular catheters, chest/abdomen drain 
tubes, and cholecystostomy.
Another possible adaptation to the 
COVID-19 environment would be optimizing 
procedures, to delay or even avoid the pa-
tient entering the hospital. For example, by 
distancing catheter exchanges in nephros-
tomy/gastrostomy tubes, or by scheduling 
patients requiring ablation and/or biopsies 
in the first part of the day so they could be 
managed as outpatients. This promotion of 
confinement would protect patients by re-
ducing or avoiding intra-hospital infection 
altogether. IR consultation optimization (1-
day pre-operative examination) and the use 
of digital platforms for patient follow-up may 
be key measures (Table 1).
Adaptation of IR physicians
Virus protection
With a higher proportion of healthcare 
professionals (HCP) affected by COVID-19, 
specific training in virus transmission and 
contagion prevention in the IR units will be 
mandatory. 
According to the information published by 
the Centre for Disease Control, the proper use 
of complete personal protective equipment 
(PPE), including respirator, will diminish high-
risk exposure, enabling a safe working envi-
ronment for staff (11). Many patients treated 
in the IR angiography suite might have an 
active COVID-19 disease. Moreover, some IR 
procedures are considered as high-risk due 
to the possibility of aerosolization, such as in-
tubation/extubation, airway/oral suctioning, 
nasogastric tube insertion, gastrostomy, tra-
cheal/esophageal/gastroduodenal stenting 
and lung biopsies/bronchial artery emboliza-
tion (3, 12).
Institutions need to provide adequate PPE 
and the education and training necessary to 
ensure its correct use to avoid contamina-
tion on clothes, skin, and the environment 
during the doffing procedure. Future edu-
cation leaders, “buddy-check systems” and 
COVID-19 checklists to accomplish these 
new protocols will be needed (12). 
Immunological evaluation
Hospitals must provide security for both 
patients and professionals by avoiding 
cross-infection. This will be reliant on the 
hospital’s epidemiological characteristics, 
as well as the availability of diagnostic tests 
(PCR and serological tests). Patient immuno-
logical status may be controlled at different 
levels, by performing tests on all patients, 
on those patients with risk factors (e.g., car-
diovascular disease, immunosuppression, 
over 70 years of age), or as a minimum, on 
those who will undergo procedures requir-
ing hospital admission. Regardless of the 
test protocol implemented, the hospital 
must be informed in advance of COVID-19 
positive patients that access the IR unit, 
the objective being to avoid complications 
caused by COVID-19 infection and contam-
ination of the otherwise clean hospital cir-
cuit (13, 14).
It is necessary to carry out immunolog-
ical and PCR tests for HCP in order to iden-
tify COVID-19 cases (Fig. 2). For asymptom-
atic professionals, this would determine 
those who can transmit the virus (PCR+) 
Main points
• Interventional radiology (IR) procedures 
have evolved in number, type and setting 
and have arguably been optimized as a di-
rect consequence of this pandemic; a result 
that will undoubtedly lead to radical change 
within the specialty.
• A reorganization of the work system must be 
devised within the IR units that caters for inpa-
tients and outpatients.
• New designs for angiography suites will be 
necessary for the future.
• The coronavirus pandemic appears to be an 
inflection point that has accelerated changes 
in medical education. The spread of the virus is 
educating us on global connectivity.
• IR will have to catch up with the other medical 
disciplines, where health management has been 
implemented and has justified their activities.
Figure 1. COVID-19 epidemic curve: Curve can be divided in emergency (disease outbreak up to 
peak), mitigation (flattening curve) and recovery phases. Normally, a return to basal situation can be 
achieved, but resurgence of a new pandemic wave can occur depending on the management of the 
mitigation phase. Each phase demands different intensity of medical specialties, hospital beds, and 
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and should remain isolated, and those who 
could work normally (PCR-). Symptomatic 
HCP should undergo a PCR study directly, 
with routine and repetitive surveillance of all 
negative HCP, depending on the stage of the 
pandemic and the recommendations of the 
local health authority at that time (13–16). 
IR work redesign
A reorganization of the work system must 
be devised within IR units that caters for in-
patients and outpatients. Prior to COVID-19 
infection, multiple outpatient tasks were 
performed within the IR unit such as angio 
CT/MRI, explorations that we could now 
consider within a non-hospital environment. 
Angio-teleradiology services could be car-
ried out at home, and thus be aligned with 
the government’s promotion of social dis-
tancing and restricted people movement. 
Clinical follow-up of patients using telemed-
icine could be introduced in the same fash-
ion. In addition to limiting the virus spread, 
these new measures may be beneficial to 
rationalize the work of IR team during crit-
ical pandemic scenarios. In this situation, 
protocols would contemplate continuity of 
patient care by distributing staff into non-in-
terchangeable fixed groups. 
Psychological impact in IR
The healthcare community is facing 
unprecedented physical and psycholog-
ical stress. The term “resilience” will be de-
finitively incorporated as one of our core 
values. In addition to the inherent stress 
associated with medical decision-making, 
we now contemplate new infectious risk 
management. COVID-19 anxiety in IR staff 
has been present from the outset due to the 
lack of adequate protective material and 
the clear instructions of its use. This anxiety 
has persisted into the second stage of the 
pandemic, with the added responsibility to 
re-fashion IR wards to cater for COVID-19 
and non-COVID-19 patients and provide 
safe and secure environments and working 
procedures at all times.
In the late pandemic period, we will be 
faced with long waiting lists for postponed 
procedures, resulting in increased workload 
on professionals, working within a specialty 
where only the highest quality of service can 
be accepted. This requirement will material-
ize in a time when we can reasonably antic-
ipate downward budgetary pressure, salary 
caps, headcount reductions, and limited 
Future of IR in the post COVID-19 era 
Figure 2. Immunological and molecular testing protocol proposed for IR personnel (could be 
modified according to the available evidence and the indications of local public health authorities).
Table 1. Procedure optimization strategies during COVID-19 pandemic
Optimization strategy Objectives Actions
1. Vascular access - Reduce hospital stay - Radial access for diagnostic and therapeutic 
procedures 
- Reduce procedure times - Vascular closure devices (7, 8)
- Social distancing
2. Drainage catheters - Reduce catheter replacement rates - Primary placement of gastrojejunostomy or 
balloon-retained gastrostomy tubes instead 
of multipurpose catheters (9)
- Reduce waiting list - High durability materials
3. Biliary system procedures - Reduce number of interventions per patient - Biliary stent placement in the same initial 
drainage procedure
- Reduce hospital stay
- Transhepatic tract embolization
4. Early discharges - Reduce hospital stay - Same-day discharge after tumoral ablation 
procedures (10) and after hepatocellular 
carcinoma chemoembolization (11)
➢ First procedure of the day
➢ Telephone follow-up the next day
➢ Use of opioid-free analgesic protocols if 
possible
➢ Use local anesthetic in all patients
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availability of resources, the obvious results 
of global recession, possibly even depression, 
the normal outcome of any pandemic.
Two types of uncertainty related to the 
disease will be presented. First, with respect 
to medical aspects of the disease (variety of 
symptoms, development of immunity, future 
medication/vaccine and possible new pan-
demic waves), and second, the personal as-
pect, related to our social-family setting (fear 
of becoming an infectious vector for our be-
loved). 
Depression, anxiety, and post-traumatic 
syndrome will be observed with a variety 
of symptoms (asthenia, anorexia, sleep dis-
order, nervousness) (17–19). As time passes 
and the pandemic stimulus ends, we will 
progressively learn to manage these situa-
tions. Disease updates and medical training 
in virus protective measures will relieve stress 
levels. Fluid communication channels that 
encourage the sharing of experiences will 
be established. Psychological support may 
be required. Leadership should especially be 
aware of burn-out and psychological pan-
demic impact amongst the teams (20).
Angiography suite adaptation to COVID-19
Significant changes are taking place in 
healthcare facilities as a consequence of 
the COVID-19 pandemic, and IR services 
have been driven to implement structural 
changes of their units. 
Improvised and non-protocol actions 
have been taken in the angiography suite 
during the emergency phase. As the sce-
nario improved, and normal activity re-
sumed, the co-existence of COVID-19 and 
non-COVID-19 patients has led to the cre-
ation of two separated circuits, supervised 
by the preventive medicine service (14, 16). 
The authors have listed below recommen-
dations to adapt IR unit facilities to the con-
ditions of the the pandemic (Table 2).
New designs for angiography suites will 
be necessary in the future. They may in-
clude disinfection corridors, negative pres-
sure rooms (airborne infection isolation), 
high air exchange cycle rate rooms, antiviral 
surface coating with zinc dioxide or silver 
nanoparticles and ultraviolet disinfection 
devices (21–23). 
Continuing medical  
education (CME) in IR
The coronavirus pandemic appears to 
be an inflection point that has accelerated 
changes in medical education. The spread 
of the virus is educating us on global con-
nectivity. Tools such as Zoom (Zoom Vid-
eo Communications Inc.), and Slack (Slack 
Technologies Inc.), have enabled simulta-
neous communication amongst hundreds 
of specialists (including IR), with medi-
cal leaders in differing countries sharing 
their experiences and learning from the 
pandemic in real time (24). Live streamed 
webinars have become the mainstay of 
medical educational platforms during the 
acute phase of COVID-19 infection, and will 
probably become standard for the future. 
The on-demand option will increase the au-
dience to IR that would prefer to consume 
the content on their terms and avoid tech-
nical risks. The drawback of webinars, how-
ever, is the limited participation, reduced 
to a non-interactive submitted question. To 
solve this lack of collaboration, the imple-
mentation of small group meetings within 
online forums is suggested. 
Medical congresses have also been af-
fected due to the COVID-19 restrictions. 
International conferences and courses such 
as GEST, CIRSE, SIR and ECIO, as well as local 
meetings have been cancelled, postponed 
or have been redesigned as “virtual”. We 
can expect new European legislation de-
tailing updated regulation with respect to 
social distancing at medical events. Virtual 
congresses may be the inevitable reality for 
the future. A complete change of mind set 
amongst physicians, and an industry-wide 
deployment plan will be required (25–27).
Social networks will allow us to share 
knowledge and collaborate in real time. For 
example, the social networks Twitter and 
WhatsApp allow people to learn and share 
information on a global scale, without the 
depth, supervision, or need to organize 
classical medical meetings. IR, however, 
will need trusted content within social net-
works in order to be effective for CME, and 
to avoid “infodemic” channels of misinfor-
mation (28).
As IR is a hands-on-learning discipline, 
IR fellows will need to learn demonstrable 
skills in the context of limited access to clin-
ical rotations and collaborative experiences. 
Live cases, recorded cases, tele-mentoring 
and IR unit rotations within safe COVID-19 
environments may solve this setback.
Artificial intelligence, robotics and virtual 
reality are highly likely to be essential com-
ponents for adaptive learning.
Despite this future trend of technology 
utilization, we cannot ignore how import-
ant face-to-face contact and in-person 
learning is for IR in the context of CME.
Table 2. Structural adaptation of IR units to COVID-19
In units with two or more angiography suites, it is recommended to establish one for COVID-19 pa-
tients and one for non-COVID-19. Separate circuits of patient management should be mandatory.
In IR units with one angiographic room, it is recommended to segregate different groups of patients. 
If possible, procedures for non-infected patients should be performed in the early hours of the day 
and those for the infected in the second part of the workday.  
Ideally, staff should not work simultaneously with both types of patients during the workday and it is 
advisable to change staff uniforms after performing procedures on COVID-19 patients. Interchange-
able personnel shifts may be employed. For example, interventional radiology staff may work for a 
week and are isolated for the following week at home. 
The equipment of COVID-19 and non-COVID-19 rooms must be separated and non-interchangeable.
In COVID-19 rooms, this equipment will be essential for operation and must be properly protected 
and disinfected.
All fixed wardrobes inside the angiography suite should be replaced by mobile wardrobes and trol-
leys.
Material storage should be redesigned to optimize access to frequently used devices and minimize 
transfers.
There should be no coexistence of COVID-19 and non-COVID-19 patients in hallways, waiting or re-
covery rooms.
It is necessary to take into account the increase in the time of transfers, procedures and cleaning 
protocols after interventions in COVID-19 patients, regardless of the complexity of the procedure.
A dedicated, specifically trained 24/7 cleaning team, with a sanitization sequence might prove to be 
a valuable resource.
Economic impact in IR
The COVID-19 pandemic has led to a 
redistribution of healthcare expenditure 
towards specific hospital units (e.g., ICU, 
internal medicine), technology (ventilators, 
portable X-ray units), personal protective 
equipment, immunological test and medi-
cations.
Global gross domestic product (GDP) is 
expected to decline by between 2.1% and 
3.9% depending on the impact of the pan-
demic, with the context of having spent up 
to 20% of its GDP on healthcare expendi-
tures (29). In this panorama of scarce pub-
lic  health resources,  prioritized to medical 
and investigative areas related to COVID-19 
pandemic, IR units' budgetary forecast will 
not be very favorable (30). From our side, 
IR is a novel specialty highly dependent on 
technology, implying high cost of interven-
tions. From an opportunity cost viewpoint 
of healthcare intervention investment, IR 
can be adversely affected (e.g., an endovas-
cular dialysis arteriovenous fistula creation 
program may be displaced by a COVID-19 
telehealth service program). Most likely 
only the scientifically well-proven inter-
ventions and emergency procedures will 
prevail following the anticipated hospital 
budgetary cuts.
Unproven technology and interventions, 
and interventions that do not reach the 
thresholds of  cost-effectiveness, may be 
suspended or replaced with alternative ap-
proaches, perhaps in some cases resulting 
in a backward step to more classical surger-
ies. IR will have to catch up with other med-
ical disciplines where health management 
has been implemented and has justified 
their activities. In this regard, deep under-
standing and implementation of healthcare 
analytics of our practice will be critical. Data 
collection and analysis, not only from a sci-
entific perspective, but also from economic 
viewpoint, will be necessary to enable bet-
ter targeting of financial resources within 
the IR sector. In evaluating cost-effective-
ness, IR has an advantageous position over 
other specialties, given the minimally inva-
sive nature of interventions and compara-
bly early hospital discharges.
In this context, IR will have to evolve, 
from optimization/standardization of in-
terventions, to well-established healthcare 
procedures, to facilitate improved relation-
ships with hospital managers within an eco-
nomically pressured environment. Medical 
supplies will also need adjustment to re-
duce the cost of IR products, with varying 
strategies, in order to achieve homogene-
ity in product cost between hospitals (e.g., 
centralized supply). Marketing will also play 
an important role in order to assure access 
of the patient to the IR units in an unstop-
pable tendency of digital media and social 
networks.
Relations with the medical 
industry
When this healthcare crisis passes, the 
healthcare sector would have been trans-
formed, perhaps unrecognizable from its 
former self. With a global view, health com-
panies with multiple divisions, or that fulfill 
the critical needs of the COVID-19 markets, 
will be in a good financial position, whilst 
others specialized in IR may experience a 
slowdown of their business. Revenue has 
fallen during the outbreak; whilst the miti-
gation phase is in progress, elective proce-
dures will return to redress business losses, 
though this does not imply that revenues 
will recover their previous levels. Payment 
disruption to providers will increase and IR 
product margins will be negatively affect-
ed. IR companies will need to create chal-
lenging strategies in diverse areas such 
as staffing, medical and financial depart-
ments.
COVID-19 has built a barrier between IR 
staff and traditional sales representatives. 
Medical centers have restricted access of 
sales representatives to hospitals in order 
to minimize the virus spread in communi-
ties. Creative marketing initiatives based 
on digital technology (webinars, videocon-
ferences with customers, podcasts) may re-
place traditional branding. Highly qualified 
product specialists may become the only 
representatives permitted access to hospi-
tal and support physicians. This tendency 
may require future restructuring of compa-
nies, resulting in job losses, while remaining 
job profiles are enhanced. 
In many countries, a great part of CME 
has relied on the healthcare industry. Social 
distancing recommendations and future 
infectious waves may alter the organization 
of traditional medical congress and events 
where the industry plays an import role by 
offering educational grants and sponsor-
ship. Industry CME support will be carried 
out through digital alternatives like webi-
nars, small group conferences, and e-learn-
ing platforms, with software to evaluate 
medical activity and patient follow-up be-
ing in high demand. 
Conclusion
The COVID-19 pandemic outbreak has 
transformed our healthcare system and 
medical practices. IR will need to adapt 
to meet the challenges of a dynamic and 
uncertain future. We will be required to 
demonstrate our new core value of resil-
ience, to adapt, to improve, to rise into 
those challenges, to streamline our IR facili-
ties and practices, to enhance relationships 
with our peers, our managers, and the med-
ical industry as a whole.  
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